ArticleScientific reports2026
Entropy quantum computing for fixed-backbone protein design.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computational protein design (CPD) is a central problem in biotechnology, with applications in enzyme engineering and therapeutic design, but its combinatorial complexity poses a significant challenge for classical optimization methods. In this work, we formulate fixed-backbone CPD as a quadratic Hamiltonian over rotamer variables, enabling solution using Quantum Computing Inc.'s photonic entropy computing platform, Dirac-3. We evaluate solution quality by benchmarking against an exact classical cost function network (CFN) solver, which provides provably optimal baselines. On a set of standard benchmark proteins ranging from 493 to 943 variables, Dirac-3 produces best-observed solutions (over 100 samples per instance) within 0.16-2.47% of the optimal energies. These results show that the proposed formulation can identify low-energy configurations on directly solvable CPD instances, while sample-level energy distributions vary by instance. Runtime behavior is reported over the tested regime, where CFN remains faster in absolute terms, while Dirac-3 exhibits moderate growth in runtime with problem size. This study focuses on optimization performance as measured by energy relative to exact baselines under a pairwise fixed-backbone energy model. Exploratory experiments on larger instances using decomposition-based approaches are provided in the Supplementary Material. Overall, the results establish a benchmark for entropy-based optimization on CPD formulations within the directly solvable regime.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.